Interesting Neuro: Alzheimer Updates & PFO Device
November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.
Neuro News Roundup: New MS Test & Stroke Risk
Studies include a potential test for MS, a link between headaches and hypothyroidism, and a risk prediction scale for stroke patients.
ANA 2016: Selective Neuronal Dysfunction
Data blitz presentations at ANA 2016 featured studies on neuronal dysfunction and degeneration in ALS, Parkinson disease, transverse myelitis, & more.
ANA 2016: Risk Factors with Neurological Disorders
Award-winning posters presented during the American Neurological Association Annual Meeting discussed risks in stroke, MS, and migraine.
Interesting Neuro: Stroke Therapy & Zika Updates
Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.
Neuro News Roundup: Potential MS Therapies
Three new multiple sclerosis studies show the promise of two drugs, amiselimod and alemtuzumab, as treatments and one, arbaclofen, for spasticity.
Interesting Neuro: ECTRIMS News & Alzheimer Marker
Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.
ECTRIMS 2016: Managing MS Symptoms
Research presented at this ECTRIMS session covered management of multiple sclerosis-related fatigue, cognitive issues, and gait impairment.
New Imaging Techniques: MS Neuroprotection & Repair
This ECTRIMS session includes studies using 7T and 3T MRI images and translocator protein PET scans, as well as phenotypes in gray matter and more.
Early Relapsing-Remitting MS: Induction vs Escalation
Hot Topics session at ECTRIMS 2016: treat early active RRMS with potent induction therapy or immunomodulation then escalation? Where do you stand?